Published
Formulation and Evaluation of SR Tablets of Anti-diabetic drug Gliclazide
Published in June 2019 Issue 3 (Vol. 9, Issue 3, 2019)

Abstract
Recent advances in Sustained Release Drug delivery System (SRDDS) aim to enhance safety and efficacy of drug molecule by formulating a convenient dosage form for administration and to achieve better patient compliance. This present study showed that the Gliclazide is an oral hypoglycemic (anti-diabetic drug) and is classified as a sulfonylurea. Its classification has been ambiguous, as literature used it as both a first generation and second generation sulfonylurea. Gliclazide was shown to protect human pancreatic beta-cells from hypoglycemia-induced apoptosis. It was shown to have an anti-atherogenic effect (preventing accumulation of fat in arteries) in type II diabetes. Gliclazide is used in the tablet form for antidiabetic effect.
Citations & discovery
Explore citations to this article and find it in scholarly databases.
Checking citation sources…
Citation counts reflect each source's coverage. Europe PMC shows DOI search matches, including mentions in references. Article lists may be incomplete. Google Scholar opens a separate search.
Authors (1)
Priya Tiwari
View all publications →Download Article
Summarise this paper with AI:
Article Information
Published in:
June 2019 Issue 3 (Vol. 9, Issue 3, 2019)Article Impact
Views:3,278
Downloads:1,291
scite_
Smart Citations
0Citing Publications
0Supporting
0Mentioning
0Contrasting
View Citations
See how this article has been cited at scite.ai
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
How to Cite
Tiwari, P. (2019). Formulation and Evaluation of SR Tablets of Anti-diabetic drug Gliclazide. American Journal of PharmTech Research, 9(3), 1-15. https://doi.org/10.46624/ajptr.2019.v9.i3.001
Article Actions
More from this Issue
Design and Development of Medicated Lollipop Containing Albendazole
Smitha Shetty, Krishnanan...Read more →
A Review On Substituted Benzimidazoles: Biologically Active Compounds
Indira. M. Madawali, Gavi...Read more →
Development of A Hospital Formulary In A Tertiary Care Hospital
Sridhar Srimath Tirumala ...Read more →
More by These Authors
Synthesis, Characterization and Biological Activities of Some Novel Heterocyclic Chalcones Derivatives
2014 • Vol. 4, Issue 6
Read more →
